@KeithTradeSmith KeithTradeSmith
Perma-bull AI-megatrend mapper pairing thematic baskets with quant seasonality timing signals
Publishes long-form bullish thematic-basket theses across th
Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY. · Analyst brief as of 2026-06-22.
Across their last 20 scored bets: 50% hit rate, -0.15% mean alpha, trader score -0.13. Their last-14d mentions, direction-adjusted, have moved -1.1% since posting (mean over 113 mentions with price data).
KeithTradeSmith is leaning into AI infrastructure beneficiaries, especially semiconductor equipment, power-grid suppliers, industrials, and niche picks-and-shovels baskets, while repeatedly framing legacy software as pressured by AI. His distinctive read is that the AI trade is broadening away from obvious megacap software into fab tools, grid hardware, manufacturing cyclicals, diagnostics, robotics suppliers, and quantum suppliers. Late in the window, he tactically flipped CRM from a bearish AI-disruption narrative into a short-term call scalp after an extreme losing streak, while still saying he wanted confirmation before trusting it.
Conviction intensified around semiconductor equipment as AMAT, LRCX, KLAC, ASML, TER, and ACMR appeared repeatedly from June 16 through June 19 as AI capex beneficiaries. CRM shows a discrete tactical flip: he spent several posts bearish or cautious on AI disruption and the losing streak, then initiated a short-term call scalp on June 17 while still avoiding full confidence without a green signal. New late-week themes surfaced in quantum suppliers, grid upgrades, robotics suppliers, and biotech ETFs, with no large personal position disclosures beyond the YPF/VIST 13F framing.
| date (PT) | ticker | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|---|
| 2026-07-03 | OCUL | @KeithTradeSmith | +0.55 | Bullish ophthalmology theme with named stocks, TAM data, AI/gene therapy and valuation points. | — | tweet ↗ |
| 2026-07-03 | HROW | @KeithTradeSmith | +0.55 | Bullish ophthalmology theme with named stocks, TAM data, AI/gene therapy and valuation points. | — | tweet ↗ |
| 2026-07-03 | ALC | @KeithTradeSmith | +0.55 | Bullish ophthalmology theme with named stocks, TAM data, AI/gene therapy and valuation points. | · | tweet ↗ |
| 2026-07-02 | META | @KeithTradeSmith | +0.10 | AI power demand thesis argues BESS is next, highlighting Fluence backlog and guidance. | — | tweet ↗ |
| 2026-07-02 | GOOG | @KeithTradeSmith | +0.10 | AI power demand thesis argues BESS is next, highlighting Fluence backlog and guidance. | — | tweet ↗ |
| 2026-07-02 | AMZN | @KeithTradeSmith | +0.10 | AI power demand thesis argues BESS is next, highlighting Fluence backlog and guidance. | — | tweet ↗ |
| 2026-07-02 | FLNC | @KeithTradeSmith | +0.65 | AI power demand thesis argues BESS is next, highlighting Fluence backlog and guidance. | — | tweet ↗ |
| 2026-07-02 | BE | @KeithTradeSmith | +0.45 | AI power demand thesis argues BESS is next, highlighting Fluence backlog and guidance. | — | tweet ↗ |
| 2026-07-02 | TQQQ | @KeithTradeSmith | +0.60 | TQQQ entered Green Zone with 100% 15-year win rate and 12.77% average gain. | — | tweet ↗ |
| 2026-07-01 | · | @KeithTradeSmith | · | References stats after crossing below 30, with weaker next-year outcome. | · | tweet ↗ |
| 2026-07-01 | PLTR | @KeithTradeSmith | -0.60 | Bearish RSI study shows PLTR often lower 12 months after RSI crosses below 30. | +2.8% | tweet ↗ |
| 2026-07-01 | SPY | @KeithTradeSmith | +0.55 | July has been positive 13 of 15 years with strong median and average returns. | -0.1% | tweet ↗ |
| 2026-06-30 | MSFT | @KeithTradeSmith | +0.65 | Bullish RSI study cites 79 occurrences, 77% higher 12M later and average returns. | +4.7% | tweet ↗ |
| 2026-06-30 | PPGN | @KeithTradeSmith | +0.35 | Frames peptide boom as multi-year bull market with listed plays and July regulatory catalyst. | · | tweet ↗ |
| 2026-06-30 | LLY | @KeithTradeSmith | +0.55 | Frames peptide boom as multi-year bull market with listed plays and July regulatory catalyst. | +1.2% | tweet ↗ |
Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.